Utilizing venous occlusion plethysmography to assess vascular effects: A study with buloxibutid, an angiotensin II type 2 receptor agonist
Abstract Buloxibutid (also known as C21) is a potent and selective angiotensin II type 2 receptor (AT2R) agonist, in development for oral treatment of fibrotic lung disease. This phase I, open‐label, pharmacodynamic study investigated vascular effects of buloxibutid in five healthy male volunteers....
Main Authors: | Erik Rein‐Hedin, Folke Sjöberg, Cecilia Ganslandt, Johan Skoog, Helene Zachrisson, Thomas Bengtsson, Carl‐Johan Dalsgaard |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-02-01
|
Series: | Clinical and Translational Science |
Online Access: | https://doi.org/10.1111/cts.13735 |
Similar Items
-
The direct effect of leg position on calf blood flow measured by venous occlusion plethysmography☆
by: Julie H. Corrigan, et al.
Published: (2007-12-01) -
CONTACTLESS MEASUREMENT OF KEY PARAMETERS OF LIMB VESSELS ON AN OCCLUSAL PLETHYSMOGRAPHY METHOD
by: V. I. Kuznetsov, et al.
Published: (2013-06-01) -
Plethysmography System to Monitor the Jugular Venous Pulse: A Feasibility Study
by: Antonino Proto, et al.
Published: (2021-12-01) -
Impedance plethysmography /
by: Faezah Zali, 1985-, et al.
Published: (2010) -
Quantitative analysis of venous outflow with photo-plethysmography in patients with suspected thoracic outlet syndrome
by: Jeanne Hersant, et al.
Published: (2022-10-01)